Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Really hope we are not too far away now……from success. It been a long road.
Same here!
Deltex Medical Group plc (AIM:DEMG) is in demand after it won a key order for its monitors.
The company, whose technology is used in critical care and general surgical procedures, said it had received a US$200,000 order from a distributor in the Americas for its TrueVue monitors.
The two have been working for 18 months to gain approval for the monitors, which measure blood flow velocity in the central circulation in real time.
Initially the distributor purchased five monitors to carry out in-hospital evaluations and these trials proved successful leading to the TrueVue technology being chosen to fulfil an initial government tender in that market.
As a result, Deltex has now received an initial order for monitors to fulfil government-awarded contracts, with installation expected over the next nine months. Further monitor orders are expected later this year once more tenders are awarded.
The order will also result in contracted monthly revenues for the single-use probes, which are used with these devices.
Once we get both then we will head to 70 and beyond.
All I am waiting for is approval in USA and China. It has been a number of years in the waiting…….
Surely our product is better than this one.
Interesting day. 2,5 volume and up 13%.
As at 13 December 2021, the Company’s investment in DVP (formerly known as Venturex Resources Limited) shares and DVP options have increased significantly to approximately US$12.74 million (or approximately HK$99.37 million) from 31 December 2020. The Company’s current fair value gain of its holding of DVP shares and DVP options together with the subscriptions and disposals of certain DVP shares during the year is approximately US$14.88 million (or approximately HK$116.06 million), representing an increase of approximately (((622.59%))) from 31 December 2020. The fair value gain for the financial year ending 31 December 2021 is subject to change based on DVP’s share price as at 31 December 2021.
Break even is a good bit off for me! Then again I still hope to more than double my initial stake here when we succeed in the USofA!
So we are doomed. Better sell up and take the huge loss. Thanks for the advice Alquemie. Do it on Monday.
?
Some positive news flow from Jamie Boy would be a bonus.
Anyone been in contact with Jim or Jamie recently?
I do wonder how many Private Investors we still have, can’t be many!
We would all like to see a supportive and productive RNS from the BOD. We tried to promote Fortacin in the UK slightly through the media. We all know that it is the USA they are waiting to for success. This is where the money is to be made. Take much longer than we all thought. Our day is still to come.
At least the is some good news!
We have had a bounce of 3%!
The name change is even more puzzling. Why do it and let the Company slide. All doesn’t make sense. Wish they would just be transparent.